Dania Marcia Vásquez Blomquist

Title: Dania Marcia Vásquez Blomquist: Innovator in Active Antiangiogenic Therapy

Introduction

Dania Marcia Vásquez Blomquist is a prominent inventor based in Ciudad de la Habana, Cuba. She has made significant contributions to the field of biotechnology, particularly in the area of active antiangiogenic therapy. Her innovative work focuses on the application of oligonucleotide and polypeptide sequences related to the vascular permeability factor (VPF).

Latest Patents

Dania holds 1 patent for her groundbreaking invention titled "Active antiangiogenic therapy." This patent details the use of specific molecular sequences in active immunotherapy for various pathological conditions associated with increased angiogenesis. The therapeutic applications of her invention include treatments for cancer, inflammatory processes, infectious diseases, autoimmune diseases, and several eye conditions, among others.

Career Highlights

Dania is affiliated with the Centro de Ingeniería Genética y Biotecnología, where she continues to advance her research and development efforts. Her work has positioned her as a key figure in the field of genetic engineering and biotechnology in Cuba.

Collaborations

Dania collaborates with Boris Ernesto Acevedo Castro, contributing to the advancement of their shared research goals. Their partnership exemplifies the collaborative spirit essential for innovation in scientific research.

Conclusion

Dania Marcia Vásquez Blomquist is a trailblazer in the field of active antiangiogenic therapy, with a focus on innovative treatments for various diseases. Her contributions to biotechnology are noteworthy and continue to impact the medical community positively.